Kamiren Xl (Doxazosin)

Doxazosin blocks alpha‑1 adrenergic receptors on vascular smooth muscle and in the prostate. This inhibition prevents norepinephrine‑induced contraction, leading to vasodilation that reduces peripheral resistance and blood pressure, while also relaxing the prostate and bladder neck to ease urinary obstruction.

The appropriate dose of Kamiren XL is individualized by a qualified prescriber based on the patient’s condition, response, and tolerability. Physicians determine the starting dose and any subsequent adjustments, so patients should follow the specific instructions provided by their healthcare professional.

Safety data for doxazosin in pregnancy and lactation are limited. It is generally classified as contraindicated or to be used only if the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their physician.

To request Kamiren XL, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with ACE inhibitors or calcium‑channel blockers, doxazosin belongs to the alpha‑1 blocker class and primarily reduces blood pressure by vasodilation rather than affecting the renin‑angiotensin system. It also offers the added benefit of treating BPH, a feature not shared by most other antihypertensives.

Kamiren XL tablets should be stored at ambient temperature, below 25 °C, in their original packaging to protect from moisture and light. Keep the container tightly closed and out of reach of children.

Kamiren XL is taken orally, usually once daily. The tablet should be swallowed whole with a glass of water and can be taken with or without food, unless the prescriber advises otherwise.

Serious adverse events include severe hypotension, syncope, priapism, and allergic reactions such as angioedema or rash. Patients should seek immediate medical attention if they experience sudden dizziness, fainting, painful prolonged erections, or signs of an allergic response.

Kamiren XL is contraindicated in patients with known hypersensitivity to doxazosin or other alpha‑1 blockers, those with severe hypotension, and individuals taking certain interacting medications such as other alpha‑blockers or potent CYP3A4 inhibitors without medical supervision.